Companies: 48,687 Total Market Cap: 127170894885349.93

Dermapharm Holding SE

LON-0A5J

Pharmaceutical Preparations

Rank #5205

Market Cap 2.39 B

Volume 2,318.56

Price 51.70

Change (%) 1.76%

Country or region

Germany

Dermapharm Holding SE's latest marketcap:

2.39 B

As of May 4, 2025, Dermapharm Holding SE's market capitalization has reached $2.39 B. According to our data, Dermapharm Holding SE is the 5205th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	2.39 B
Revenue (ttm)	1.31 B
Net Income (ttm)	124.81 M
Shares Out	0
EPS (ttm)	2.32
Forward PE	0.00
Ex-Dividend Date	June 27, 2025
Earnings Date	May 15, 2025

Market Cap Chart

Data Updated: May 4, 2025

Dermapharm Holding SE's yearly market capitalization.

Dermapharm Holding SE has seen its market value drop from £2.77 B to £1.76 B since 2020, representing a total decrease of 36.53% and an annual compound decline rate (CAGR) of 9.98%.

Date	Market Cap	Change (%)
April 28, 2025	£1.76 B	1.31%
December 30, 2024	£1.74 B	-12.22%
December 29, 2023	£1.98 B	10.4%
December 30, 2022	£1.79 B	-55.58%
December 30, 2021	£4.03 B	45.52%
December 30, 2020	£2.77 B

Company Profile

Company Overview

Dermapharm Holding SE, along with its subsidiaries, specializes in the manufacturing and sale of off-patent branded pharmaceutical products primarily in Germany.

Business Segments

Branded Pharmaceuticals
Other Healthcare Products
Parallel Import Business

Product Portfolio

The company offers a diverse range of products, including:

Branded generics and OTC products
Non-prescription healthcare products and herbal extracts
Parallel-imported originator pharmaceuticals
Vitamins, minerals, and food supplements
Dermatology, allergology, and pain/inflammation treatments
Cardiovascular, gynecology, and urology products
Cosmetics and medical devices

Key Brands

Dermapharm markets its products under well-known brands such as:

Dekristol
Keltican
Tromcardin
Ketozolin
bite away
Herpotherm

Corporate Details

Founded in 1991 and headquartered in Grünwald, Germany, Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG.

Frequently Asked Questions

As of May 4, 2025, Dermapharm Holding SE (including the parent company, if applicable) has an estimated market capitalization of $2.39 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Dermapharm Holding SE global market capitalization ranking is approximately 5205 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Germany
Founded	1991
IPO Date	n/a
Employees	3,610
CEO	Hans-Georg Feldmeier
Sector
Industry	Pharmaceutical Preparations
Address	Lil-Dagover-Ring 7 Grünwald, 82031 Germany